BRIEF-Catalyst Pharmaceuticals Q4 non-gaap loss per share $0.05 excluding items By: Reuters: Company News March 15, 2017 at 17:08 PM EDT * Catalyst pharmaceuticals announces fourth quarter and year-end 2016 financial results and provides corporate update Read More >> Related Stocks: Catalyst Pharm Inc